INSIGHTS ON CLINICAL TRIAL DESIGN
-
How Different Are Oncology Clinical Trials?
Oncology clinical trials pose unique challenges. Dive into five key reasons behind the intricacies of oncology trials, from recruitment hurdles to data volume and efficacy endpoints.
-
Unify Your Data With A Centralized eClinical Platform
Despite the challenges associated with large volumes of data, maintaining quality and regulatory compliance, and enhancing patient engagement, the solutions for managing them can be simple and efficient.
-
Establishing A Culture Of Quality: What Every CMO Should Know
Learn to adequately recognize the fundamental components of a quality-driven culture, unlock the means to foster such a culture, and grasp the advantages and consequences.
-
Evolving Trial Master Files Require Experienced TMF Resourcing
Inexperienced individuals will often produce a TMF that falls short in terms of quality, completeness, or timeliness. Unlock the secret to maintaining an up-to-date and inspection-ready TMF.
-
Improving Patient Engagement And Retention With Mobile Nurse Visits4/5/2024
We analyze dropout data and speak to DCT expert Ellen Weiss to explore the power of mobile visits in improving patient engagement and retention rates.
-
Revolutionizing Traditional Medicine With Cannabis-Based Medicinal Products1/25/2023
Read how the key to implementing the use of cannabinoids to treat pain or other conditions is in continued research to identify the ideal cannabinoid components and doses for different indications.
-
Creating Understanding And Partnership In The Rare Disease Community2/15/2023
Explore why 97% of respondents in a survey agreed that providing technology solutions for patient engagement in clinical trials can positively impact recruitment and retention.
-
Decentralized Clinical Trials: Meeting Patients Where They're At7/12/2023
Discover how innovations in DCTs are removing barriers in clinical research and medicine development to improve patient participation.
-
Immune Checkpoint Inhibitors Global Clinical Trials Landscape (2023)11/27/2023
Dive into the forefront of immune checkpoint inhibitors clinical trials with an exploration of the latest trends and key findings.
CLINICAL TRIAL DESIGN SOLUTIONS
-
Altasciences recruits from a large ethnic population in Southern California and have a dedicated Asian recruitment and outreach department to liaise with our participants.
-
With experience overseeing thousands of Phase I studies in the US and Canada, Advarra’s institutional review board (IRB) understands the unique requirements of Phase I study design and conduct. Our dedicated team and processes are built to support your Phase I research needs.
-
Advisory and execution services to efficiently advance new drugs and devices to market.
-
Discover more about this specialized training program focused on mitigating the placebo response, aimed at diminishing its influence.
-
Traditional clinical trial models can create financial burden by neglecting participant needs – but effective use of stipends can allow participants to fully engage without financial worries.